Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


20.6000 USD 0.3500 1.73%

As of 12:45:29 ET on 05/22/2015.

Snapshot for Depomed Inc (DEPO)

Open: 20.4100 Day's Range: 20.1400 - 20.6700 Volume: 516,262
Previous Close: 20.2500 52wk Range: 9.8500 - 28.1600 1-Yr Rtn: +79.18%

Stock Chart for DEPO

No chart data available.
  • DEPO:US 20.6000
  • 1D
  • 1M
  • 1Y
Interactive DEPO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DEPO

Current P/E Ratio (ttm) 14.6126
Estimated P/E(12/2015) 80.0103
Relative P/E vs. SPX 0.7883
Earnings Per Share (USD) (ttm) 1.3872
Est. EPS (USD) (12/2015) 0.2520
Est. PEG Ratio -
Market Cap (M USD) 1,215.46
Shares Outstanding (M) 59.96
30 Day Average Volume 1,844,160
Price/Book (mrq) 3.4285
Price/Sale (ttm) 3.4968
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DEPO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DEPO

DepoMed, Inc. develops new and proprietary oral drug delivery technologies. The Company has developed a system designed to be retained in the stomach for an extended period of time while it delivers the incorporated drug or drugs. DepoMed has also developed a system designed to reduce gastrointestinal irritation.

James A Schoeneck "Jim"President/CEOAugust J MorettiSenior VP/CFO/Investor Relations
Richard Scott ShivelySenior VP/Chief Commercial OfcrSrinivas G RaoSenior VP/Chief Medical Officer
More Company Profile & Key Executives for DEPO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil